Related Experiment Video
Updated: Jun 10, 2025

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Anesthetic Approach for a Pediatric Patient With Facioscapulohumeral Muscular Dystrophy
Conceição C Santos1, Carla I Ferreira1, Erica Carvalho1
1Anesthesiology and Perioperative Medicine, Hospital de Braga, Braga, PRT.
Facioscapulohumeral muscular dystrophy (FSHD) poses risks during anesthesia. This case report details the successful anesthetic management of a pediatric FSHD patient, including sugammadex for neuromuscular blockade reversal.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Neuromuscular Disorders
Background:
- Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic myopathy.
- Patients with muscular dystrophies have increased risks for intraoperative complications like hyperkalemia and rhabdomyolysis.
- General anesthesia in pediatric patients with FSHD is not well-documented.
Observation:
- This report details the anesthetic management of a pediatric patient with FSHD undergoing an exploratory tympanotomy.
- The anesthetic approach focused on mitigating known risks associated with muscular dystrophies.
- Neuromuscular blockade reversal was achieved using sugammadex.
Findings:
- Successful general anesthesia was administered to a pediatric patient with FSHD.
- The anesthetic plan effectively managed potential intraoperative complications.
- Sugammadex was safely and effectively used for neuromuscular blockade reversal in this context.
Implications:
- This case provides valuable insights into anesthetic considerations for pediatric FSHD patients.
- It highlights the potential utility of sugammadex in this specific patient population.
- Further research into anesthetic protocols for rare neuromuscular disorders is warranted.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Pharmocokinetics

